pharma · Duchenne Muscular Dystrophy · Gastroparesis · PCSA
Processa Pharmaceuticals
Processa Pharmaceuticals is a pharma organization headquartered in Hanover, USA. It trades on NYSE under ticker PCSA. Primary therapeutic focus areas include Duchenne Muscular Dystrophy, Gastroparesis, Necrobiosis Lipoid
Hanover, USA HQ
16 Employees
Public company Type
PCSA · NYSE Ticker
Company details
- Status
- Public
- HQ
- Hanover, USA
- Employees
- 16
- Programs
- 8
- Drugs
- 2
- Patents
- 0
RX-3117
Phase 2 · small molecule · Solid Tumor
RX-3117 for Solid Tumor is a Phase 2 program (small_molecule) at Processa Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Internal code RX-3117-P1-01
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Processa Pharmaceuticals
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- Solid Tumor
- Status
- completed
- Trials
- 1